Real-Time Polymerase Chain Reaction With Fluorescent Hybridization Probes for the Detection of Prevalent Mutations Causing Common Thrombophilic and Iron Overload Phenotypes
Open Access
- 1 March 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 115 (3) , 439-447
- https://doi.org/10.1309/3h1w-v6nh-n3p9-rhfj
Abstract
We evaluated more than 450 patients with thrombophilia or iron overload for the presence of a factor V Leiden (R506Q), prothrombin G20210A, or HFE C282Y mutation using a standard method (polymerase chain reaction [PCR]–restriction fragment length polymorphism) and a comparative real-time PCR fluorescent resonance energy transfer (FRET) hybridization probe melting curve method. There was 100% concordance between the genotypes ascertained by the 2 methods (at each loci). In addition, phenotypic biochemical laboratory parameters measured on a subset of referred patients correlated with their respective genotypes. In the iron overload cohort, HFE C282Y homozygotes (n = 74) had significantly higher (P < .0001) transferrin saturation levels (74% –25%) than did nonhomozygotes (n = 340; 51.4% –28%), suggesting a genotype-dependent increase in body iron loads. In the thrombophilic cohort, the degree of activated protein C resistance (APCR), measured by a clotting time–based test, was associated significantly with the presence of 0 (n = 255; APCR = 2.59 –0.26), 1 (n = 84; APCR = 1.61 –0.13), or 2 (n = 5; APCR = 1.16 –0.04) copies of the mutant factor V Leiden allele. As the fluorescent genotyping method required no postamplification manipulation, genotypes could be determined more quickly and with minimized risk of handling errors or amplicon contamination. In addition to these practical advantages, the FRET method is diagnostically accurate and clinically predictive of phenotypic, disease-associated manifestations.Keywords
This publication has 18 references indexed in Scilit:
- Hereditary HemochromatosisArchives of Pathology & Laboratory Medicine, 1999
- Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis ScreeningAnnals of Internal Medicine, 1998
- Homogeneous Multiplex Genotyping of Hemochromatosis Mutations with Fluorescent Hybridization ProbesThe American Journal of Pathology, 1998
- Hepatic Iron Overload: Direct HLA-HMutation AnalysisvsQuantitative Iron Assays for the Diagnosis of Hereditary HemochromatosisAmerican Journal of Clinical Pathology, 1998
- The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand bindingProceedings of the National Academy of Sciences, 1998
- Risk of venous thrombosis in carriers of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase*Molecular Diagnosis, 1997
- Hereditary hemochromatosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Factor V Leiden and Risks of Recurrent Idiopathic Venous ThromboembolismCirculation, 1995
- Molecular Detection of a Common Mutation in Coagulation Factor V Causing Thrombosis via Hereditary Resistance to Activated Protein CDiagnostic Molecular Pathology, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995